Related Experiment Video
Updated: Jan 2, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Increased systemic inflammation in children with Down syndrome
Dean Huggard1, Lynne Kelly2, Emer Ryan2
1Paediatrics, Trinity College, The University of Dublin, Ireland; Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, Ireland; Paediatrics, Children's Hospital Ireland (CHI) at Tallaght, Tallaght University Hospital, Ireland; National Children's Research Centre, CHI at Crumlin, Dublin, Ireland.
Insights
Children with Down syndrome (DS) show higher levels of inflammatory and anti-inflammatory cytokines, impacting infection and autoimmunity risks. These cytokine differences may explain varied clinical outcomes in DS patients.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Children with Down syndrome (DS) experience increased infections, sepsis mortality, and chronic inflammatory conditions.
- Cytokine dysregulation is implicated in DS clinical sequelae, with elevated pro-inflammatory biomarkers noted in adults.
- The roles of anti-inflammatory mediators (IL-1ra, IL-10) and cytokines (Epo, VEGF) in DS, particularly concerning congenital heart disease (CHD), are not fully understood.
Purpose of the Study:
- To comprehensively examine pro-inflammatory (IL-2, IL-6, IL-8, IL-18, IL-1β, TNF-α, IFN-γ) and anti-inflammatory (IL-10, IL-1ra) mediators in children with DS.
- To investigate the influence of hypoxia-related (EPO), angiogenesis-related (VEGF), and myelopoiesis-related (GM-CSF) cytokines.
- To discuss the impact of congenital heart disease (CHD) and lipopolysaccharide (LPS) on these mediators.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to quantify a wide range of cytokines.
- 114 children with Down syndrome and 60 age/sex-matched controls were recruited.
- Analysis included baseline cytokine levels and responses to LPS stimulation.
Main Results:
- Children with Down syndrome exhibited significantly higher baseline levels of pro-inflammatory cytokines (IL-2, IL-6), anti-inflammatory cytokines (IL-10, IL-1ra), and other mediators (Epo, VEGF, GM-CSF).
- Congenital heart disease (CHD) did not appear to significantly alter circulating cytokine levels outside the acute surgical phase.
- Both Down syndrome and control groups showed similar responses when stimulated with LPS.
Conclusions:
- Elevated pro- and anti-inflammatory cytokine profiles in children with Down syndrome may contribute to their increased susceptibility to infections and autoimmune conditions.
- These distinct cytokine patterns could underlie the varied clinical outcomes observed in Down syndrome.
- Further research into these cytokine differences is warranted to understand and potentially mitigate clinical sequelae in DS.
Abstract:
Children with Down syndrome (DS) develop more infections, have an increased mortality from sepsis and an increased incidence of chronic inflammatory conditions. Cytokine dysregulation may underpin these clinical sequelae and raised pro-inflammatory biomarkers are a feature in adults with DS. The importance of the anti-inflammatory mediators IL-1ra and IL-10, as well as cytokines Epo and VEGF, which could impact on the pathogenesis and outcomes in congenital heart disease (CHD) which is more prevalent in DS, are less well known. We examined a comprehensive array of pro-(IL-2, IL-6, IL-8, IL-18, IL-1β, TNF-α, IFN-γ), and anti-inflammatory (IL-10 and IL-1ra) mediators, cytokines involved in inflammation in response to hypoxia (EPO), propagating angiogenesis (VEGF), and myelopoiesis (GM-CSF), by enzyme linked immunosorbent assay (ELISA), as well as discussing the potential impact of significant CHD and Lipopolysaccharide endotoxin on these mediators. 114 children with DS and 60 age and sex matched controls were recruited. Children with Down syndrome exhibit significantly greater levels of pro and anti-inflammatory cytokines; IL-2, IL-6, IL-10, IL-1ra, as well as increased Epo, VEGF and GM-CSF at baseline. CHD does not seem to have an impact on circulating cytokines beyond the acute surgical phase. Both cohorts had similar responses to LPS stimulation. These differences may contribute to varied clinical outcomes, acutely like in sepsis, and over time in autoimmunity.
More Related Videos
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Rheumatic Heart Disease I: Introduction